DrugBiological

Trastuzumab clinical trials

Also written Herceptin, PF-05280014, rhuMAb HER2 and Herzuma.

Includes 4 studies of CT-P6, 1 study of Ontruzant and 1 study of ABP-980.

studies test it: 614
open now: 88
in phase 3: 94
first study started: 1998

Keep track of what changes. Save the Trastuzumab studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Biosimilars in development

PF-05280014: 7
HLX02: 2
SIBP-01: 2
EG12014: 2
SB3: 2
QL1701: 1
ALT02: 1

Studies by the year they started

612 studies that test it; most in 2011 (42); 1 more planned to start later

Studies that test Trastuzumab, by start year
Year	Studies
1998	4
1999	17
2000	17
2001	20
2002	15
2003	9
2004	17
2005	27
2006	28
2007	31
2008	19
2009	22
2010	17
2011	42
2012	16
2013	32
2014	27
2015	21
2016	15
2017	20
2018	18
2019	23
2020	24
2021	30
2022	28
2023	26
2024	15
2025	18
2026	14

By phase

A phase 1/2 study counts in both.

Early Phase 1: 4
Phase 1: 148
Phase 2: 415
Phase 3: 94
Phase 4: 14
No phase: 15

What it is tested for

Each study’s main condition, where its own words name it.

Breast Neoplasms: 383
Stomach Neoplasms: 38
Adenocarcinoma: 15
Carcinoma: 14
Neoplasms: 13
Colorectal Neoplasms: 12
Breast Neoplasms, Male: 11
Colonic Neoplasms: 5
Biliary Tract Neoplasms: 5
Triple Negative Breast Neoplasms: 5
Carcinoma, Non-Small-Cell Lung: 4
Inflammatory Breast Neoplasms: 4

Who runs them

Industry 166 · Other 448

Hoffmann-La Roche (49) · National Cancer Institute (NCI) (36) · Dana-Farber Cancer Institute (16) · Fudan University (15) · Memorial Sloan Kettering Cancer Center (15) · Novartis Pharmaceuticals (14) · M.D. Anderson Cancer Center (11) · City of Hope Medical Center (9)

Often tested with

Tested in the same studies.

Pertuzumab (98) · Paclitaxel (93) · Docetaxel (59) · Capecitabine (47) · Carboplatin (40) · Cyclophosphamide (40) · Lapatinib (31) · Doxorubicin (29)

Studies

Open first, then newest update. How each study uses Trastuzumab is read from its arms, and is right about nine times in ten.

Testing it · 614

See all 614 studies that test Trastuzumab →

Given in every arm · 196 — Trastuzumab is usual care beside what is tested

Showing 20 of 196.

As the comparator · 71 — what is tested is compared with Trastuzumab

Showing 20 of 71.

Codes

What other systems call Trastuzumab · ClinicalTrials.gg INT006553

MeSH (NLM) D000068878TrastuzumabConfirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA) P188ANX8CKTRASTUZUMABConfirmed FDA, NLM, Wikidata
RxNorm 224905Confirmed FDA, Wikidata
Wikidata Q412616trastuzumabConfirmed FDA, NLM, Wikidata
NCI Thesaurus C1647TrastuzumabOne source FDA
DrugBank DB00072One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	D000068878	Trastuzumab	Confirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA)	P188ANX8CK	TRASTUZUMAB	Confirmed FDA, NLM, Wikidata
RxNorm	224905	—	Confirmed FDA, Wikidata
Wikidata	Q412616	trastuzumab	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C1647	Trastuzumab	One source FDA
DrugBank	DB00072	—	One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.